190 related articles for article (PubMed ID: 210834)
21. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
Tkachuk VA; Lazarevich VG; Men'shikov MIu; Severin SE
Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
[TBL] [Abstract][Full Text] [Related]
22. Proteolytic activation of Ca2+-dependent cyclic nucleotide phosphodiesterase from Escherichia coli.
Iwasa Y
Horm Metab Res; 1981 Jul; 13(7):414-5. PubMed ID: 6268507
[TBL] [Abstract][Full Text] [Related]
23. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
24. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
25. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
Davis CW; Daly JW
Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
[No Abstract] [Full Text] [Related]
26. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Lugnier C; Gauthier C; Le Bec A; Soustre H
Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
[TBL] [Abstract][Full Text] [Related]
27. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
Kuo JF; Shoji M; Brackett NL; Helfman DM
J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
[TBL] [Abstract][Full Text] [Related]
28. Cyclic nucleotide phosphodiesterase activity in cardiac and vascular smooth muscle of the spontaneously hypertensive rat.
Taylor JE; Shirachi DY
Proc West Pharmacol Soc; 1977; 20():307-10. PubMed ID: 197543
[No Abstract] [Full Text] [Related]
29. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
Strada SJ; Martin MW; Thompson WJ
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
[No Abstract] [Full Text] [Related]
30. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
Hidaka H; Endo T
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
[No Abstract] [Full Text] [Related]
31. Differential regulation of calcium-dependent and calcium-independent cyclic nucleotide phosphodiesterases from heart by palmitoylcarnitine and palmitoyl coenzyme A.
Katoh N; Helfman DM; Wrenn RW; Kuo JF
Biochim Biophys Acta; 1982 Jan; 714(1):129-35. PubMed ID: 6275902
[TBL] [Abstract][Full Text] [Related]
32. [Properties of cyclic nucleotide phosphodiesterase of the rabbit myometrium in various functional states].
Kurskiĭ MD; Osipenko AA; Prishchepa LA
Biokhimiia; 1984 Jul; 49(7):1096-102. PubMed ID: 6089916
[TBL] [Abstract][Full Text] [Related]
33. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
34. Cyclic nucleotide phosphodiesterase. Insulin activation detected in adipose tissue by gel electrophoresis.
Solomon SS; Palazzolo M; King LE
Diabetes; 1977 Oct; 26(10):967-72. PubMed ID: 198322
[TBL] [Abstract][Full Text] [Related]
35. Regulation by a beta-adrenergic receptor of a Ca2+-independent adenosine 3',5'-(cyclic)monophosphate phosphodiesterase in C6 glioma cells.
Onali P; Schwartz JP; Hanbauer I; Costa E
Biochim Biophys Acta; 1981 Jul; 675(2):285-92. PubMed ID: 6268187
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
Ilien B; Landry Y
Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
[No Abstract] [Full Text] [Related]
37. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
38. Regulation of cyclic nucleotide phosphodiesterase activity.
Vaughan M; Danello MA; Manganiello VC; Strewler GJ
Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
[No Abstract] [Full Text] [Related]
39. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle.
Pizarro M; Puente J; Sapag-Hagar M
FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696
[No Abstract] [Full Text] [Related]
40. Resolution of soluble rat cardiac phosphodiesterases by high performance liquid chromatography.
Bode DC; Kanter JR; Brunton LL
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):235-40. PubMed ID: 2856111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
